SHENGTAI PHARMACEUTICAL, INC. Increase (Decrease) in Accounts Receivable
SHENGTAI PHARMACEUTICAL, INC. reported Increase (Decrease) in Accounts Receivable of $1.28 million for the 9-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2013-05-15
- SHENGTAI PHARMACEUTICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2013-03-31 was $2.00M, a 214.59% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2012-12-31 was $1.08M, a 4.77% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was -$1.80M.
- SHENGTAI PHARMACEUTICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was $2.78M.
- SHENGTAI PHARMACEUTICAL, INC. increase (decrease) in accounts receivable for fiscal 2012 was $3.36M.
- SHENGTAI PHARMACEUTICAL, INC. increase (decrease) in accounts receivable for fiscal 2011 was -$68.92K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2013-03-31 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $3.08M derived: sum of 2 quarters · filed 2013-05-15 | $1.28M 10-Q · filed 2013-05-15 | $4.06M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-12-31 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$721.11K 10-Q · filed 2013-02-14 | $2.06M derived: sum of 3 quarters · filed 2013-02-14 | $2.69M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-09-30 | -$1.80M 10-Q · filed 2012-11-14 | $977.12K derived: sum of 2 quarters · filed 2012-11-14 | $1.61M derived: sum of 3 quarters · filed 2013-05-15 | $2.64M derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-06-30 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | $3.41M derived: sum of 2 quarters · filed 2013-05-15 | $4.44M derived: sum of 3 quarters · filed 2013-05-15 | $3.36M 10-K · filed 2012-09-28 |
| 2012-03-31 | $636.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $1.67M derived: sum of 2 quarters · filed 2013-05-15 | $578.62K 10-Q · filed 2013-05-15 | -$2.58M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$58.33K 10-Q · filed 2013-02-14 | -$3.22M derived: sum of 3 quarters · filed 2013-02-14 | -$5.49M derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | -$1.09M 10-Q · filed 2012-11-14 | -$4.25M derived: sum of 2 quarters · filed 2012-11-14 | -$6.51M derived: sum of 3 quarters · filed 2012-11-14 | -$324.00 derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | -$5.43M derived: sum of 2 quarters · filed 2012-09-28 | $1.09M derived: sum of 3 quarters · filed 2012-09-28 | -$68.92K 10-K · filed 2012-09-28 |
| 2011-03-31 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $4.25M derived: sum of 2 quarters · filed 2012-05-15 | $3.09M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $6.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $5.36M 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | -$1.16M 10-Q · filed 2011-11-14 |